US 12421317
Polynucleotides encoding anti-glucagon-like peptide 1 receptor (GLP1R) antagonist antibodies
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 12421317 (Polynucleotides encoding anti-glucagon-like peptide 1 receptor (GLP1R) antagonist antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K9/0019, A61P